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a  b  s  t  r  a  c  t
Peripheral  nerve  repair  can  be enhanced  by  Schwann  cell  transplantation,  but the clinical  application  of
this  procedure  is  limited  by  donor  site morbidity  and  the  inability  to quickly  generate  a sufﬁcient  number
of  cells.  Thus,  alternative  cell  systems  for the generation  of  Schwann  cells  are  desired.  Schwann-like
cell  induced  from  adipose-derived  stem  cells  (ADSCs)  may  be one  of the  ideal  alternative  cell  systems
for  Schwann  cell  generation.  Although  co-culture  with  Schwann  cells  or  chemicals  combined  with  a
mixture  of  glial  growth  factors  are  often  utilized  for  Schwann  cell-like  differentiation  of ADSCs,  these
methods  are  usually  complicated  or expensive.  In this  experiment,  the  rat sciatic  nerve  was  cut,  and  then
soaked  in  culture  medium  for two days.  The  treated  culture  medium  was  used as  an  induction  agent
after  ﬁltering.  The  obtained  ADSCs  were  incubated  with  the  above  induction  culture  medium  for  ﬁve
days.  Then,  expression  of  the  typical  Schwann  cell  markers,  S-100  and  GFAP  proteins  was  determined  by
immunocytochemical  staining  and  Western  blotting.  The  results  showed  that almost  all  of  the  treated
ADSCs  displayed  a  spindle  shape  like  morphology  after  being  incubated  with induction  culture  medium
for  24  h and  expressed  S-100  and  GFAP  proteins  after  ﬁve  days. All  of these  characteristics  of  differentiated
rat  ADSCs  were  similar  to  genuine  Schwann  cells.  Thus,  this  new  method,  which  utilized  trophic  factors
secreted  from  sciatic  nerve  leachate,  was  capable  of inducing  ADSC  differentiation  into  Schwann-like  cell.
he Au© 2013 T
. Introduction
There is a high incidence of peripheral nerve injuries throughout
he world, and these injuries represent a major economic bur-
en for society. Despite surgical advances, functional recovery of
atients is relatively poor. Schwann cells are key regulators of the
egeneration process of the injured nervous tissue that provide
tructural support and guidance for peripheral nerve regenera-
ion following injury by releasing neurotrophic factors [33]. When
     
∗ Corresponding author. Tel.: +86 15838570625.
E-mail address: lymzq@126.com (Z. Zhang).
304-3940 ©  2013 The Authors. Published by Elsevier Ireland Ltd. 
ttp://dx.doi.org/10.1016/j.neulet.2013.07.012
Open access under CC BYthors. Published by Elsevier Ireland Ltd. 
seeded in artiﬁcial nerve conduits, Schwann cells have been shown
to enhance nerve regeneration [14,19,26]. Transplanted Schwann
cells remyelinate demyelinated axons of the CNS and restore their
normal conduction properties [10]. However, cultured Schwann
cells have limited clinical application because one or more func-
tional nerves must be sacriﬁced to culture them, and this process
leads to additional morbidity, because the time required to cul-
ture and expand the Schwann cells delays treatment [34]. Thus
alternative cell systems are desirable.
In the last few years, adipose tissue has been shown to possess
a population of multi-potent stem cells, termed adipose-derived
stem cells (ADSCs) [36]. These cells are able to self-renew with
a high growth rate and differentiate along several mesenchymal
Open access under CC BY-NC-ND license.tissue lineages, including adipocytes, osteoblasts, myocytes, chon-
drocytes, endothelial cells and cardiomyocytes [9,36]. ADSCs may
also be induced into neurospheres and neuronal-like cells in vitro
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chwann-like cells [13,22]. Other groups have even shown the
otential of differentiated ADSCs to myelinate neurons in vitro,
hich could ultimately provide functional beneﬁts for peripheral
erve repair [13].
Currently,  co-culture with Schwann cells or chemicals com-
ined with a mixture of glial growth factors was often used for
chwann-like cell differentiation of ADSCs [13,16]. However, these
ethods are usually complicated or expensive. In this experi-
ent, we administered trophic factors secreted from sciatic nerve
eachate to rat ADSCs to induce the ADSCs to differentiate into
chwann cells. Our results showed that rat ADSCs can be effectively
ifferentiated into Schwann-like cell by adding trophic factors
xuded from sciatic nerve leachate.
. Methods
.1. Isolation and culture of ADSCs
Procedures involving animals and their care were conducted
n conformity with institutional guidelines that are in compliance
ith the EEC Council Directive 86/609. All efforts were made to
ini-mize animal suffering and reduce the number of animals used.
nstitutional ethical committee approval was obtained prior to con-
ucting the experiments. Three-week-old, male Sprague-Dawley
ats were used for the isolation of rat ADSCs. Animals were housed
nder standard conditions. The inguinal fat pad was harvested
fter the rats were sacriﬁced, and rat ADSCs were isolated using
 published method [27]. Brieﬂy, the adipose tissue was  dissoci-
ted mechanically for 80 min  at 37 ◦C using 0.1% collagenase type I
Gibco). The suspension was centrifuged to separate the ﬂoating
dipocytes from the stromal vascular fraction. Cells in the stro-
al vascular fraction were then maintained at 37 ◦C with 5% CO2
n Dulbecco’s modiﬁed Eagle’s medium (DMEM, Gibco) supple-
ented with 10% fetal bovine serum (FBS, Gibco). After 24 h, the
on-adherent cells were eliminated by changing the medium. Rat
DSCs were passaged 3–5 times before being used.
.2. Characterization of stem cell properties
Rat ADSCs within 3–5 passages were used to verify their multi-
otential differentiation capacity. Cells were grown to at least
0% conﬂuency before being cultured in the induction medium.
o induce adipogenic differentiation, rat ADSCs were cultured for
4 days in DMEM supplemented with 10% FBS, 0.5 mM  isobutyl-
ethylxanthine (IBMX), 1 M dexamethasone, 10 M insulin, and
00 M indomethacin. Adipogenic differentiation was  conﬁrmed
y staining with Oil-Red O. To induce osteogenic differentiation, rat
DSCs were cultured for 21 days in DMEM supplemented with 10%
BS, 100 nM dexamethasone, 50 M ascorbate-2-phosphate, and
0 mM beta-glycerophosphate. Calcium deposition was visualized
y staining with Alizarin Red S.
Immunophenotype analysis of ADSCs was performed with ﬂow
ytometry. Rat ADSCs within 3–5 passages were harvested by
rypsinization/ethylene diamine tetraacetic acid (EDTA), and then,
he cells were ﬁxed in neutral 4% paraformaldehyde solution for
0 min. The ﬁxed cells were washed twice with PBS and incubated
ith FITC coupled antibodies against rat CD31, CD44, CD45 and
D90 (all from AbD Serotec) in the dark at room temperature for
0 min. Rat ADSCs were ﬁxed with paraformaldehyde for 15 min
fter cells were washed with PBS. A ﬂow cytometer (calibur, BD,
SA) was used to analyze the samples..3. Induction of rat ADSCs into Schwann-like cells
We  ﬁrst prepared induction culture medium. In detail, rat sciatic
erves were cut into 1-cm fragments, and then soaked in the cultureters 551 (2013) 79– 83
medium  (DMEM) supplemented with 10% fetal bovine serum (FBS).
After two  days, the culture medium was  ﬁltered through 80-m
metal mesh to remove the rat sciatic nerve fragment. Subsequently,
leachate was  ﬁltered through a 0.22-m strainerfor asepsis. Rat
ADSCs within passage 3–5 were used for the experiment. Brieﬂy,
culture medium was removed from subconﬂuent cultures of ADSCs
and replaced with induction culture medium. Cells were then incu-
bated under this condition for ﬁve days. The induction culture
medium was changed every 1–2 days.
2.4. Immunoﬂuorescence staining and Western blotting
For  immunophenotype characterization of differentiated
ADSCs, the Schwann cell markers, including S-100 and GFAP,
were used. Undifferentiated and differentiated ADSCs cultured
on coverslips were ﬁxed in 4% paraformaldehyde for 10 min  and
permeabilized with 0.05% Triton X-100 for 10 min. Nonspeciﬁc
binding sites were blocked using 5% goat serum for 30 min. Anti-
glial ﬁlament acidic protein (GFAP, mouse monoclonal, 1:400,
Chemicon, USA) and anti-S-100 protein (mouse monoclonal,
1:500, abcam, UK) were then added, and then, incubated overnight
at 4 ◦C. FITC and CY3-conjugated goat anti-mouse (Chemicon)
secondary antibodies were incubated with the cells at room
temperature for 1 h. Cell nuclei were labeled with DAPI. Finally,
we examined the cells with a ﬂuorescence microscope (BX51,
OLYMPUS).
For Western blotting, the cells were extracted with lysis buffer
(50 mm Tris–HCl, pH 7.4, 150 mm NaCl, 1% Triton X-100, 0.1%
SDS, 1 mm EDTA, 1 mm Na3VO4, 1 mm NaF and a protease cock-
tail) on ice for 30 min  and then centrifuged at 12,000 × g at 4 ◦C.
Supernatants containing total protein were harvested. Fifty micro-
grams protein were prepared per sample, combined with laemmli
buffer and denatured at 95 ◦C for 5 min. Proteins were sepa-
rated by 10% SDS–PAGE and transferred to PVDF membranes.
The membranes were blocked for 1 h in 5% bovine serum albu-
min, and then incubated overnight at 4 ◦C with mouse anti-GFAP
(1:200, LabVison, USA), mouse anti-S100 (1:750, Chemicon, UK)
and -actin (1:1000, Santa Cruz Biotechnology, USA) antibodies.
The membranes were washed three times with TBS-Tween prior
to incubation with horseradish peroxidase-conjugated secondary
antibodies. Membranes were then washed again, treated with
enhanced chemiluminescence (ECL) (GE Health Care Bio-Sciences,
Piscataway, NJ, USA) and developed by exposure to Kodak light-
sensitive ﬁlm. The intensity and molecular weight of the bands
were quantiﬁed using the software Scion Image for Windows, ver-
sion 4.02 (Scion Corp., Frederick, MD,  USA). -actin was served as
control.
3. Results
3.1. Identiﬁcation of rat ADSCs
Rat ADSCs within 3–5 passages appeared as a mono-
layer of large and ﬂat cells without cytoplasmic extensions
(Fig. 1A). Flow cytometry analysis of rat ADSCs within 3–5 pas-
sages showed that the cultured ADSCs were positive for CD44
and CD90, and negative for CD31 and CD45 (Fig. 2). After
ADSCs were treated by certain induction medium, adipocyte
differentiation was conﬁrmed by lipid droplets with oil red
O, and osteoblast differentiation was assessed by production
of calcium deposits detected by staining with Alizarin Red
S. ADSCs could undergo adipogenic (Fig. 1B) and osteogenic
(Fig. 1C) differentiation in certain induction medium. This demon-
strated the multipotential differentiation characteristics of rat
ADSCs.
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Fig. 1. Multi-directional differentiation characterization of ADSCs. (A) Undifferentiated ADSCs appeared as a mono-layer of large and ﬂat cells without cytoplasmic exten-












tifferentiation was  assessed by production of calcium deposits detected by staining w
n certain induction medium. Scale bar, B = 25 m;  C = 30 m.  (D) After ADSCs are 
uclei similar to that of Schwann cells. Scale bar = 100 m.
.2. Differentiated ADSCs exhibit Schwann-like cell morphology
Some  bipolar, spindle-like cells began to appear at 12 h after
nduction, and nearly all of cells showed bi- or tri-polar, elongated
pindle shapes at 24 and 48 h after induction. Differentiated ADSCs
isplayed thin cytoplasmic extensions and large nuclei similar to
hat of Schwann cells (Fig. 1D). These spindle-like cells could con-
inue to proliferate, and the density of the cells could be much
igher.
ig. 2. Flow cytometric analysis of rat ADSCs. Rat ADSCs within 3–5 passages were harvest
hat  CD45 and CD31 are negative, but CD44 and CD90 positive.lizarin Red S. ADSCs could undergo adipogenic (B) and osteogenic (C) differentiation
d by sciatic nerve leachate, cells displayed thin cytoplasmic extensions and large
3.3. Expression of S-100 and GFAP proteins were conﬁrmed by
immunoﬂuorescence and Western blotting
Immunocytochemistry showed that most cells were positive
for S-100 (Fig. 3A) and GFAP (Fig. 3B). All of the characteristics of
differentiated rat ADSCs were similar to genuine Schwann cells.
To conﬁrm that the results obtained by immunocytochem-
istry  were not due to an artifact of cellular shrinkage, Western
blotting was performed. Lysates of differentiated ADSCs but not
ed and speciﬁc cell surface antigens were detected. Flow cytometric analysis shows
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Fig. 3. Expression of S-100 and GFAP proteins were conﬁrmed by immunoﬂuo-
rescence.  After rat ADSCs were incubated by sciatic nerve leachate for ﬁve days,
expression of S-100 and GFAP proteins were detected by ﬂuorescence microscopy.
Immunoﬂuorescence shows that almost all of the rat ADSCs are positive for S100
(A) and GFAP (B). CY3 and FITC-labeled secondary antibody were used and nuclei
were counterstained with DAPI (blue). Scale bar, A = 30 m;  B = 25 m.  (For inter-
pretation  of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
Fig. 4. Expression of S-100 and GFAP proteins were conﬁrmed by Western blotting.








tSCs) lysates were blotted for GFAP, S100 proteins. -actin was  used as control.
he  result shows that changes of ADSCs after induction by sciatic nerve leachate in
rotein expression levels are similar to genuine Schwann cells.
ndifferentiated ADSCs showed a GFAP-immunoreactive band. S-
00 proteins were also detected in differentiated ADSCs but absent
n undifferentiated ADSCs (Fig. 4).. Discussion
Embryonic stem cells can theoretically differentiate into all cell
ypes but there are ethical considerations around their clinicalters 551 (2013) 79– 83
application.  Therefore, adult stem cells have become a more
attractive alternative for cell therapy. The ﬁrst type of adult stem
cell discovered was the bone marrow-derived stem cells (BMSCs)
[23]. There is some evidence that BMSCs can be differentiated
into Schwann cells [5,11,17], and these cells have therefore been
an attractive cell source for the regeneration of nerve tissue [5].
However, harvesting of BMSCs is highly invasive and painful,
and alternative sources from which to isolate mesenchymal stem
cells should be investigated [13]. Subsequently, a cell population
with similar characteristics was isolated from adipose tissue and
named adipose-derived stem cells (ADSCs) [36]. The phenotypic
and gene expression proﬁles of ADSCs are similar to BMSCs [4,30],
and ADSCs can also be differentiated into neuronal-like cells under
speciﬁc environments [1,22,31]. Compared with BMSCs, ADSCs are
more abundant and easier to harvest, and an increasing number of
studies are therefore investigating the possibility of using ADSCs
for stem cell transplantation instead of BMSCs [20,25]. In recent
years, many studies have shown that ADSCs are able to improve
nerve regeneration in vivo and in vitro [6,8,24].
It has been reported that the phenotype of stem-derived
Schwann-like cell depends on a cocktail of extrinsic factors, such
as forskolin, platelet derived growth factor (PDGF), basic ﬁbroblast
growth factor (bFGF) and -heregulin (HRG) for maintenance. Upon
withdrawal of those factors, the cells revert to a stem-cell-like state
[22,28]. FSK increases the level of intracellular cyclic adenosine
monophosphate (cAMP), which increases mitogenic responses,
possibly by stimulating the expression of P0 protein and mRNA,
which are necessary for myelin-related differentiation [12]. PDGF
can induce Schwann cell proliferation in the presence of serum
and FSK [3]. HRG is a subtype of neuregulin-1 and neuregulin-1
is now regarded as the pivotal signal that controls Schwann cells
at every stage of their lineage [21]. bFGF functions as a mito-
gen for mesenchymal cells, and MAP  kinases are activated by
PDGF and bFGF in marrow stroma cells [2]. cAMP elevation has
a synergistic effect on Schwann cells proliferation with growth fac-
tors, including bFGF, PDGF, HRG [28]. The mixture of cytokines
mentioned above may  induce ADSCs into Schwann-like cells. In
addition, there is some previous evidence that Schwann cells can
also support their own survival in an autocrine manner by secret-
ing a cocktail of survival factors, which has been shown in vitro to
include insulin-like growth factor 2 (IGF2), neurotrophin 3 (NT3),
platelet-derived growth factor- (PDGFB), leukemia inhibitory fac-
tor (LIF) and lysophosphatidic acid (LPA) [7,18,32]. Therefore,
Zurita performed indirect co-culture of Schwann cells and BMSCs
in Transwell culture dishes and conﬁrmed BMSCs neural trans-
differentiation [37]. Subsequently, Liao et al. demonstrated that
co-culture with Schwann cells is also an effective method for
adipose-derived stem cells to undergo neural transdifferentiation
[15,16].
Although a chemical method or Schwann cell co-culture to
induce ADSC differentiation appear to be plausible methods for
acquiring sufﬁcient Schwann cells, these methods have weak-
nesses. To maintain a Schwann cell phenotype in vitro, chemicals
must be combined with multiple growth factors, such as PDGF, NGF,
bFGF, GGF and BDNF [16]. These growth factors, however, is rather
expensive, and induction procedure is extremely complicated. Co-
culture seems a simple way for Schwann-like cell differentiation
of ADSCs, however, culture of Schwann cells in vitro is difﬁcult,
because they are often mingled by ﬁbroblas which exist in the
axolemma.
We aimed to evaluate the potential of ADSCs to differenti-
ate into Schwann-like cells by leachate of the sciatic nerve. Our
results demonstrated that ADSCs can be easily differentiated into
Schwann-like cells in vitro by the above mentioned approach and
that this approach is as effective as induction by chemicals com-
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his method is simple and economical and may  thus be a promis-
ng strategy for the induction of ADSC neural transdifferentiation,
lthough the exact mechanism of this strategy is unknown. Adult
chwann cells can likely produce a number of neurotrophic fac-
ors, such as BDN, NGF and NT-3, that make it possible for stem
ells to differentiate into neuro-like cells [7,18,32,35]. Following
erve injury, a variety of growth factors, such as those mentioned
bove, are secreted from nerve stumps [23]. Therefore, we cut the
ciatic nerve into a fragment, creating a scenario similar to nerve
njury, and soaked it in culture medium for two days. It is possible
hat many growth factors run off from the sciatic nerve and enter
he culture medium. Then, the sciatic nerve leachate was  used as
n induction agent for Schwann cell-like differentiation of ADSCs.
o avoid exposure of the ADSCs to other components of the sciatic
erve, the leachate was ﬁltered by strainer mesh in our experi-
ents. This excludes the possibility of cell fusion. Although the
ethod described above is effective and practical for ADSC neu-
al transdifferentiation, further investigation is needed to detect
hat factors were secreted by the sciatic nerve and which factor(s)
layed a key role in the Schwann-like cell differentiation of ADSCs.
Most interestingly, we attempted to induce Schwann-like cell
ifferentiation of rat ADSCs with sciatic nerves from different ani-
als, including rat, rabbit, guinea pig, dog and even toad. The results
emonstrated that there were identical induction effects despite
he different genera (data not shown). This indicates that identical
actors that promote Schwann cell-like differentiation of ADSCs are
ecreted by different animals. In other words, sciatic nerves from
ny species can be used as induction agents for neural transdif-
erentiation of ADSCs, suggesting that this extensive resource (the
ciatic nerve) can be utilized for Schwann cell-like differentiation
f ADSCs. Thus, this method may  be promising for the induction of
DSC neural transdifferentiation by nerve leachate.
. Conclusion
This study shows that rat ADSCs can be effectively differenti-
ted into Schwann-like cells by adding trophic factors exuded from
erve leachate. This new method may  be promising for the induc-
ion of ADSC neural transdifferentiation in vitro.
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